Division of Biomedical Physics in Radiation Oncology, DKFZ German Cancer Research Center, 69120 Heidelberg, Germany.
Department of Physics and Astronomy, Heidelberg University, 69120 Heidelberg, Germany.
Int J Mol Sci. 2022 May 3;23(9):5077. doi: 10.3390/ijms23095077.
We propose a novel mechanism by which cancer cells can modulate the oxygen concentration within the nucleus, potentially creating low nuclear oxygen conditions without the need of an hypoxic micro-environment and suited for allowing cancer cells to resist chemo- and radio-therapy. The cells ability to alter intra-cellular oxygen conditions depends on the amount of cholesterol present within the cellular membranes, where high levels of cholesterol can yield rigid membranes that slow oxygen diffusion. The proposed mechanism centers on the competition between (1) the diffusion of oxygen within the cell and across cellular membranes that replenishes any consumed oxygen and (2) the consumption of oxygen in the mitochondria, peroxisomes, endoplasmic reticulum (ER), etc. The novelty of our work centers around the assumption that the cholesterol content of a membrane can affect the oxygen diffusion across the membrane, reducing the cell ability to replenish the oxygen consumed within the cell. For these conditions, the effective diffusion rate of oxygen becomes of the same order as the oxygen consumption rate, allowing the cell to reduce the oxygen concentration of the nucleus, with implications to the Warburg Effect. The cellular and nucleus oxygen content is indirectly evaluated experimentally for bladder (T24) cancer cells and during the cell cycle, where the cells are initially synchronized using hydroxeaurea (HU) at the late G1-phase/early S-phase. The analysis of cellular and nucleus oxygen concentration during cell cycle is performed via (i) RT-qPCR gene analysis of hypoxia inducible transcription factors (HIF) and prolyl hydroxylases (PHD) and (ii) radiation clonogenic assay every 2 h, after release from synchronization. The HIF/PHD genes allowed us to correlate cellular oxygen with oxygen concentration in the nucleus that is obtained from the cells radiation response, where the amount DNA damage due to radiation is directly related to the amount of oxygen present in the nucleus. We demonstrate that during the S-phase cells can become hypoxic in the late S-phase/early G2-phase and therefore the radiation resistance increases 2- to 3-fold.
我们提出了一种新的机制,通过该机制,癌细胞可以调节细胞核内的氧气浓度,从而在不需要缺氧微环境的情况下创造低核氧条件,并适合癌细胞抵抗化疗和放疗。细胞改变细胞内氧气条件的能力取决于细胞膜中胆固醇的含量,其中高水平的胆固醇可产生使氧气扩散减缓的刚性膜。所提出的机制集中在(1)细胞内氧气的扩散和穿过细胞膜的扩散之间的竞争,这种扩散可以补充任何消耗的氧气,以及(2)线粒体、过氧化物酶体、内质网(ER)等消耗氧气之间的竞争。我们工作的新颖之处在于假设膜的胆固醇含量会影响氧气穿过膜的扩散,从而降低细胞补充细胞内消耗氧气的能力。在这些条件下,氧气的有效扩散速率与氧气消耗速率相当,从而使细胞能够降低细胞核中的氧气浓度,这对沃伯格效应有影响。膀胱(T24)癌细胞的细胞和核氧含量以及细胞周期中,通过(i)使用羟基脲(HU)在晚期 G1 期/早期 S 期对细胞进行初始同步化,对细胞和核氧含量进行了间接评估。通过(i)缺氧诱导转录因子(HIF)和脯氨酰羟化酶(PHD)的 RT-qPCR 基因分析以及(ii)从同步释放后每 2 小时进行的辐射克隆形成测定,对细胞周期中的细胞和核氧浓度进行了分析。HIF/PHD 基因使我们能够将细胞氧与从细胞辐射反应中获得的核内氧浓度相关联,其中由于辐射导致的 DNA 损伤量与核内存在的氧气量直接相关。我们证明,在 S 期,细胞在晚期 S 期/早期 G2 期可能变得缺氧,因此辐射抗性增加 2 至 3 倍。